MAIA Biotechnology (MAIA) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free MAIA Stock Alerts $3.81 -0.04 (-1.04%) (As of 04:10 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17, 2024 | businesswire.comMAIA Biotechnology to Present at the BIO International Convention 2024May 16, 2024 | businesswire.comMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingMay 15, 2024 | investorplace.comMAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024April 30, 2024 | businesswire.comMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementApril 29, 2024 | marketwatch.comMAIA Biotechnology Shares Hit 52-Week High After Director Stock PurchaseApril 29, 2024 | businesswire.comMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementApril 28, 2024 | finance.yahoo.comMAIA Biotechnology, Inc. (MAIA)April 27, 2024 | insidertrades.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Ngar Yee Louie Acquires 19,665 SharesApril 26, 2024 | marketbeat.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires $39,919.95 in StockMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) Director Ngar Yee Louie acquired 19,665 shares of the firm's stock in a transaction on Thursday, April 25th. The stock was acquired at an average cost of $2.03 per share, with a total value of $39,919.95. Following the acquisition, the director now owns 1,167,189 shares of the company's stock, valued at $2,369,393.67. The purchase was disclosed in a document filed with the SEC, which is available through this link.April 23, 2024 | businesswire.comMAIA Biotechnology Announces $1.00 Million Private PlacementApril 5, 2024 | businesswire.comMAIA Biotechnology to Present at Two Investor Conferences in April 2024April 4, 2024 | msn.comeFFECTOR shelves tomivosertib in NSCLC following Phase II failureMarch 28, 2024 | investing.comMAIA Biotechnology directors buy shares amid development pushMarch 28, 2024 | businesswire.comMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroMarch 26, 2024 | businesswire.comMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementMarch 26, 2024 | businesswire.comMAIA Biotechnology Announces $1.33 Million Private PlacementMarch 22, 2024 | businesswire.comMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private PlacementMarch 21, 2024 | businesswire.comMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory BoardMarch 16, 2024 | insidertrades.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Buys $199,999.80 in StockMarch 16, 2024 | finance.yahoo.comDirector Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)March 14, 2024 | msn.comMAIA Biotechnology rises 3% on $2.92M private placementMarch 7, 2024 | finance.yahoo.comMAIA Biotechnology to Participate in the 36th Annual ROTH ConferenceMarch 7, 2024 | investing.comMAIA Biotechnology nears end of Phase 2 cancer trialMarch 6, 2024 | markets.businessinsider.comMAIA Announces Positive Data From Phase 2 THIO Clinical Trial For NSCLC; Stock Rises 8%March 6, 2024 | finance.yahoo.comMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingMarch 6, 2024 | businesswire.comMAIA Biotechnology and Nationwide Children's Hospital Announce Presentation of THIO's Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingMarch 6, 2024 | businesswire.comMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer PatientsMarch 5, 2024 | finance.yahoo.comMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to ShareholdersFebruary 27, 2024 | globenewswire.comMAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific AdvisorFebruary 23, 2024 | msn.comMAIA Biotechnology concludes subject enrolment in NSCLC therapy trialFebruary 22, 2024 | finanznachrichten.deMAIA Biotechnology, Inc.: MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung CancerFebruary 22, 2024 | globenewswire.comMAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung CancerFebruary 8, 2024 | benzinga.comLatest News for MAIA Biotechnology Stock (AMEX:MAIA)February 7, 2024 | stockhouse.comMAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung CancerFebruary 6, 2024 | benzinga.comNovel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDAJanuary 31, 2024 | msn.comMAIA Biotechnology Patent Boosts Cancer Treatment PotentialJanuary 24, 2024 | finance.yahoo.comMAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting CompoundsJanuary 18, 2024 | msn.comMAIA Soars 20% on Interim Results From Lung Cancer StudyJanuary 12, 2024 | msn.comMNTS, VVPR and BETS among pre-market losersJanuary 5, 2024 | finance.yahoo.comMAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024December 26, 2023 | money.usnews.comOnconetix IncDecember 21, 2023 | msn.comGalecto stock rallies 25% on positive data for myelofibrosis drugDecember 20, 2023 | msn.comMAIA Biotechnology selects dose in Phase II NSCLC trialDecember 19, 2023 | finance.yahoo.comMAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung CancerDecember 16, 2023 | msn.comMAIA Biotechnology (MAIA) Price Target Increased by 10.89% to 14.28December 1, 2023 | finance.yahoo.comBears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' NowNovember 28, 2023 | msn.com‘The Artful Dodger’ Review: Hulu Gives Dickens a TwistNovember 17, 2023 | finance.yahoo.comMAIA Biotechnology Announces Closing of $4 Million Registered Direct OfferingNovember 16, 2023 | benzinga.comMAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain CancerNovember 15, 2023 | msn.comWhy MAIA Biotechnology Stock Is Nosediving During Wednesday's Session Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… MAIA Media Mentions By Week MAIA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼0.240.45▲Average Medical News Sentiment MAIA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼11▲MAIA Articles Average Week Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ANEB News IMMX News ELDN News CALC News TLSA News KZR News KRON News CARM News EGRX News AEON News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersThis could mean the end of the U.S dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThis military-backed stock “owns” AI marketPorter & CompanyU.S. Drone Company Receives DoD CertificationThe Tomorrow Investor Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
